CompletedPhase 4

L-Arginine Role for Stone Lower Ureter : A Randomized Control Study

Egypt153 participantsStarted 2023-07-01

Plain-language summary

To evaluate the effects of L-Arginine 1000mg once daily as a medical expulsive therapy (MET) for lower ureter stones.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: Patients older than 18 years old, ureter stones in size between 4 and 10 mm, single stone Exclusion criteria: Acute azotemia, stones larger than 10 mm, solitary kidney, symptomatic urinary system infection, impacted status, severe hydronephrosis, multiple or bilateral stones, pregnancy, anatomic urinary system abnormalities, benign prostate hyperplasia.

What they're measuring

Spontaneous stone expulsion rates (SER)

Timeframe: From 1st renal colic till the time of stone pass or for four weeks

Stone expulsion time

Timeframe: From 1st renal colic till the time of stone pass or for four weeks

Number of daily colic episodes

Timeframe: number of colicky attack From 1st renal colic till the time of stone pass or for four weeks

Total required analgesic dosage

Timeframe: From 1st renal colic till the time of stone pass or for four weeks

Trial details

NCT IDNCT06753526

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Stone Lower Ureter trials